Cargando…
Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial
PURPOSE: Given the coronavirus disease 2019 (COVID-19) pandemic, there is a global urgency to discover an effective treatment for patients withthis disease. This study aimed to evaluate the effects of the widely used antiparasitic drug ivermectin on outcomes in patients with COVID-19. METHODS: In th...
Autores principales: | Shahbaznejad, Leila, Davoudi, Alireza, Eslami, Gohar, Markowitz, John S., Navaeifar, Mohammad Reza, Hosseinzadeh, Fatemeh, Movahedi, Faeze Sadat, Rezai, Mohammad Sadegh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101859/ https://www.ncbi.nlm.nih.gov/pubmed/34052007 http://dx.doi.org/10.1016/j.clinthera.2021.04.007 |
Ejemplares similares
-
Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial”
por: Shahbaznejad, Leila, et al.
Publicado: (2021) -
Clinical Characteristics and Outcomes of COVID-19 in Children in Northern Iran
por: Shahbaznejad, Leila, et al.
Publicado: (2021) -
Knowledge, attitude and practice of Sari birth cohort members during early weeks of COVID-19 outbreak in Iran
por: Shahbaznejad, Leila, et al.
Publicado: (2021) -
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials
por: Rezai, Mohammad Sadegh, et al.
Publicado: (2022) -
Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran
por: Shahbaznejad, Leila, et al.
Publicado: (2020)